CD19 and B-cell chronic lymphocytic leukemia: Similarly, a previous study on B-CLL revealed the participation of β2-integrin in cell-to-cell adhesion induced by CD19 [47], a major B-cell receptor independent activator of MYC-driven B-cell neoplastic growth [48].